VoluSense is a venture-backed medical device company focused on pulmonary health.
The company is situated in Bergen, Norway, and led by:
Rianne Vogels, CEO.
10 yrs experience from seed and venture capital, mainly in the medical technology and life science sectors.
MSc degrees in medical science and business. Chartered Financial Analyst. Tel: +47 9158 8339. Email
Kjell Øygarden, cofounder.
19 yrs at GE. Development experience from ultrasound technology and contrast agents. 8 years experience from international pre-clinical and clinical collaborations. 3 years experience from technology transfer. MSc in biophysics and medical technology.
Board of directors
Sveinung Hole, chairman. Managing Partner Sarsia Seed. Prev. Director for Anaesthesia at Haukeland University Hospital.
Kjell Øygarden, MSc. 19 yrs at GE. Development experience from ultrasound technology and contrast agents.
Kjell Arne Ingebrigtsen. Former Chairman and CEO of GE-Vingmed Ultrasound. Professor emeritus NTNU.
Arne Grip. Former CEO MediStim (Oslo Exchange: MEDI).
Jan Olaf Tønnevold. President/ Chairman at O.T. Tønnevold Group.
Clinical investigators and advisors
Prof. Michael Davis, PhD, Paediatric respiratory medicine, Montreal children's hospital, Canada.
Prof. Dr Med Urs Frey, PhD, Head Dept. of paediatric respiratory medicine, Bern University Children's Hospital, Switzerland.
Associate Prof. Graham Hall, PhD, School of peadiatrics and child health, University of Western Australia.
Dr Med Thomas Halvorsen, Children's center, Haukeland university hospital, Bergen, Norway.
Prof. Sailesh Kotecha, Prof. of child healh, Wales College of Medicine, Cardiff University, UK.
Dr Paul Seddon, Royal Alexandra Children Hospital, Brighton, UK.
Partners
HotSwap
DesignIt